SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-24-019793
Filing Date
2024-07-18
Accepted
2024-07-18 20:02:51
Documents
2
Period of Report
2024-07-18

Document Format Files

Seq Description Document Type Size
1 form3-07192024_120747.html 3  
1 form3-07192024_120747.xml 3 9535
2 ex24-07192024_120749.htm EX-24 5260
  Complete submission text file 0001415889-24-019793.txt   16250
Mailing Address 5505 MOREHOUSE DRIVE SAN DIEGO CA 92121
Business Address 5505 MOREHOUSE DRIVE SAN DIEGO CA 92121 (858) 267-4467
Artiva Biotherapeutics, Inc. (Issuer) CIK: 0001817241 (see all company filings)

IRS No.: 863614316 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O ARTIVA BIOTHERAPEUTICS, INC. 4747 EXECUTIVE DRIVE, STE. 1150 SAN DIEGO CA 92121
Business Address
Huh Yong-Jun (Reporting) CIK: 0001931083 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-42179 | Film No.: 241125800